Advanced search
Publication Cover
Acta Cardiologica Latest Articles
Submit an article Journal homepage
0
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Ischaemic and haemorrhagic risk distribution in real-life patients with acute coronary syndromes

Federico Weckessera ICBA – Instituto Cardiovascular de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Mirza Riverob CEMIC, Buenos Aires, ArgentinaView further author information
,
Diego Condea ICBA – Instituto Cardiovascular de Buenos Aires, Buenos Aires, ArgentinaCorrespondence[email protected]
View further author information
,
Gonzalo Perezc Clinica Olivos, Buenos Aires, ArgentinaView further author information
,
Ezequiel Zaideld Sanatorio Guemes, Buenos Aires, ArgentinaView further author information
,
Cristian Garmendiaa ICBA – Instituto Cardiovascular de Buenos Aires, Buenos Aires, ArgentinaView further author information
,
Pierre Sabourete Heart Institute and Action Group, Pitié-Salpétrière, Sorbonne University, Paris, FranceView further author information
,
Marcelo Trivia ICBA – Instituto Cardiovascular de Buenos Aires, Buenos Aires, ArgentinaView further author information
&
Juan Pablo Costabela ICBA – Instituto Cardiovascular de Buenos Aires, Buenos Aires, ArgentinaView further author information
 show all
Received 26 Nov 2023, Accepted 02 Jun 2024, Published online: 18 Jun 2024

References

  • Pham PA, Pham PT, Pham PC, et al. Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention. Vasc Health Risk Manag. 2011;7(1):551–567. doi: 10.2147/VHRM.S23862.
  • Wang TKM, Mehta OH, Liao YWB, et al. Meta-analysis of bleeding scores performance for acute coronary syndrome. Heart Lung Circ. 2020;29(12):1749–1757. doi: 10.1016/j.hlc.2020.04.008.
  • Kirtane AJ, Pocock SJ, Ayele GM, et al. Bleeding events before coronary angiography in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2016;68(24):2608–2618.
  • Andó G, Costa F. Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? Postepy Kardiol Interwencyjnej. 2015;11(3):170–173. doi: 10.5114/pwki.2015.54007.
  • Costabel JP, Zaidel E, Rivero M, et al. Registro multicéntrico prospectivo de pacientes hospitalizados por síndrome coronario agudo sin elevación del segmento ST en centros de alta complejidad. Resultados intrahospitalarios y evolución a 6 meses (Buenos Aires I). Rev Argent Cardiol. 2020;88(4):308–316. doi: 10.7775/rac.es.v88.i4.18501.
  • Fox KAA, Eagle KA, Gore JM, et al. The Global Registry of Acute Coronary Events, 1999 to 2009-GRACE. Heart. 2010;96(14):1095–1101. doi: 10.1136/hrt.2009.190827.
  • GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141(2):190–199.
  • Ariza-Solé A, Sánchez-Elvira G, Sánchez-Salado JC, et al. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res. 2013;132(6):652–658. doi: 10.1016/j.thromres.2013.09.019.
  • Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-sT-segment-elevation myocardial infarction the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation. 2009;119(14):1873–1882. doi: 10.1161/CIRCULATIONAHA.108.828541.
  • Guerrero C, Ariza-Solé A, Formiga F, et al. Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction. J Geriatr Cardiol. 2018;15(12):713–717.
  • Kadiyala V, Long S, Has P, et al. PRECISE-DAPT and ARC-HBR predict in-hospital outcomes in patients who underwent percutaneous coronary intervention. Am J Cardiol. 2023;191:43–50.
  • Ueki Y, Bär S, Losdat S, et al. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention. 2020;16(5):371–379. doi: 10.4244/EIJ-D-20-00052.
  • Okabe K, Miura K, Shima Y, et al. Comparison and validation of long-term bleeding events for Academic Bleeding Risk (ARC-HBR) criteria and contemporary risk scores for percutaneous coronary intervention with a second-generation drug eluting stent. Circ J. 2022;86(9):1379–1387. doi: 10.1253/circj.CJ-21-0901.
  • VanHouten JP, Starmer JM, Lorenzi NM, et al. Machine learning for risk prediction of acute coronary syndrome. AMIA Annu Symp Proc. 2014;2014:1940–1949.
  • Ariza-Solé A, Salazar-Mendiguchía J, Lorente V, et al. Predictive ability of bleeding risk scores in the routine clinical practice. Eur Heart J Acute Cardiovasc Care. 2015;4(3):205–210. doi: 10.1177/2048872614538405.
  • Abu-Assi E, Raposeiras-Roubin S, Lear P, et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2012;1(3):222–231. doi: 10.1177/2048872612453924.
  • Navarro Estrada JL, Constantin I, Gonzalez N, et al. Consenso para el manejo de pacientes con Síndrome Coronario Agudo sin Supradesnivel del Segmento ST (Angina Inestable e Infarto de Miocardio sin elevación del ST) Consenso de la Sociedad Argentina de Cardiología. Rev Argent Cardiol. 2014;81(1):2248–2261.
  • Trivi M, Lakowsky A, Zeballos C, et al. Prospective registry of antithrombotic therapy in acute coronary syndromes (EPICOR). Rev Argent Cardiol. 2019;87(1):1–8.
  • Poldervaart JM, Langedijk M, Backus BE, et al. Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department. Int J Cardiol. 2017;227:656–661.
  • Lindholm D, Varenhorst C, Cannon CP, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35(31):2083–2093.
  • Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–1057. doi: 10.1056/NEJMoa0904327.
  • Roe MT, Armstrong PW, Fox KAA, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367(14):1297–1309. doi: 10.1056/NEJMoa1205512.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.